Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Hemant Murthy

BMT · Mayo Clinic Florida

View

Dr. Talal Hilal

Lymphoma · Mayo Clinic College of Medicine

View

Dr. Midhun Malla

GI Oncology · UAB

View

Dr. Saad Usmani

Myeloma · MSK

View

Dr. Kamal Menghrajani

Leukemia · MGH

View

Dr. Hope Rugo

Breast Oncology · City of Hope

View

Dr. Gideon Dosunmu

GI Oncology · Emory Hospital Midtown

View

Dr. Pavlos Msaouel

GU Oncology · MD Anderson Cancer Center

View

Dr. Virginia Borges

Breast Oncology · CU Anschutz Medical Campus

View

Dr. Naval Daver

Leukemia · MD Anderson Cancer Center

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    WGDr. Wayne Godfrey

    Dr. Wayne Godfrey

    Hematology & Oncology · Bone Marrow Transplant (BMT)
    wayne

    Research

    Combinations of idelalisib with rituximab and/or bendamustine in patients with recurrent indolent non-Hodgkin lymphoma

    2016

    Via Blood Advances

    Research

    PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma

    2014

    Via The New England Journal of Medicine

    Research

    Idelalisib, a selective inhibitor of phosphatidylinositol 3-kinase-δ, as therapy for previously treated indolent non-Hodgkin lymphoma

    2014

    Via Blood

    Research

    A phase 1 study of the PI3Kδ inhibitor idelalisib in patients with relapsed/refractory mantle cell lymphoma (MCL)

    2014

    Via Blood

    Research

    Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer

    2010

    Via Journal of Clinical Oncology

    Research

    NF90 regulates inducible IL-2 gene expression in T cells

    2007

    Via The Journal of Experimental Medicine

    Research

    NF90 regulates cell cycle exit and terminal myogenic differentiation by direct binding to the 3'-untranslated region of MyoD and p21WAF1/CIP1 mRNAs

    2005

    Via The Journal of Biological Chemistry

    Research

    CD4+CD25+ regulatory T-cell lines from human cord blood have functional and molecular properties of T-cell anergy

    2005

    Via Blood

    Research

    In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures

    2004

    Via Blood

    Research

    Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function

    2004

    Via Blood

    Research

    Ex vivo depletion of alloreactive cells based on CFSE dye dilution, activation antigen selection, and dendritic cell stimulation

    2003

    Via Blood